P.086 EVALUATION OF ARTERIAL DISTENSIBILITY IN HYPERTENSIVE PATIENTS TREATED WITH IRBESARTAN
Main Authors: | A. Vicente Casanova*, J. Redón i Más, J. Aznar Vicente |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-06-01
|
Series: | Artery Research |
Online Access: | https://www.atlantis-press.com/article/125929957/view |
Similar Items
-
Determinants of persistence in hypertensive patients treated with irbesartan: results of a postmarketing survey
by: Greminger Peter, et al.
Published: (2005-06-01) -
Clinical case: Effectiveness of combined therapyOrlistat and Irbesartan at the Metabolic syndrome patient with Arterial hypertension
by: K P Ivanov, et al.
Published: (2009-03-01) -
The combination therapy in arterial hypertension: opportunities of the fixed combination of irbesartan andhydrochlorothiazide(Koaprovel’)
by: O D Ostroumova, et al.
Published: (2014-09-01) -
Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension
by: Peter Bramlage
Published: (2009-02-01) -
Irbesartan improves arterial compliance more than lisinopril
by: Khalid Ali, et al.
Published: (2009-07-01)